A5011427559- Glioma Diagnosis and Treatment
- Neuroblastoma Research and Treatments
- Lung Cancer Research Studies
- Management of metastatic bone disease
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
- Prostate Cancer Treatment and Research
- Advanced MRI Techniques and Applications
- Brain Metastases and Treatment
- Surgical site infection prevention
- Advanced Electron Microscopy Techniques and Applications
- Myasthenia Gravis and Thymoma
- Acute Ischemic Stroke Management
- Intracerebral and Subarachnoid Hemorrhage Research
- Neurosurgical Procedures and Complications
- Meta-analysis and systematic reviews
- Circular RNAs in diseases
- MicroRNA in disease regulation
- Bipolar Disorder and Treatment
- Cancer-related molecular mechanisms research
Zhejiang University
2023-2025
First Affiliated Hospital Zhejiang University
2023-2024
Fujian Medical University
2020
Fujian Provincial Cancer Hospital
2020
Wenzhou Medical University
2017
First Affiliated Hospital of Wenzhou Medical University
2017
Abstract Purpose: Glioblastoma (GBM) is a highly vascularized tumor with few treatment options after disease recurrence. Here, we report the efficacy and safety of anlotinib hydrochloride plus temozolomide in patients recurrent GBM. Patients Methods: first definite postsurgical progression histologically confirmed GBM preceded by standard radiotherapy chemotherapy were eligible for inclusion. All received (150–200 mg/m2, orally, every day (QD) d1–5/4 wk) (10 mg, QD, d1–14/3 until or...
<p>A. An MR image revealed a hyperintense signal in the DWI sequence, indicating an acute ischemic stroke right ACA region (white arrows). B. CT angiography showed poor visualization of distal ACA.</p>
<p>Supplementary figure 6. Wound dehiscence.</p>
<p>A-B. Kaplan-Meier plots of progression-free survival and overall (Full analysis set). The x-axes indicated times since enrollment.</p>
<p>Axial, sagittal and coronal gadolinium-enhanced FLAIR MRI at pre-baseline (A-D). Three months later, demonstrated progressive disease after anlotinib plus temozolomide (E-H).</p>
<p>A-B. Kaplan-Meier plots of progression-free survival and overall (Full analysis set). The x-axes indicated times since enrollment.</p>
<p>Axial, sagittal and coronal gadolinium-enhanced MRI at pre-baseline (A-C; yellow arrows), 6 months later demonstrating complete response after anlotinib plus temozolomide (E-G). Axial Fluid-Attenuated Inversion Recovery (FLAIR, D) image pre-baseline, no progression was observed during treatment (H).</p>
<div>Abstract<p>Background: Glioblastoma (GBM) is a highly vascularized tumor with few treatment options after disease recurrence. Here, we report the efficacy and safety of anlotinib hydrochloride plus temozolomide in patients recurrent GBM. Methods: Patients first definite postsurgical progression histologically confirmed GBM preceded by standard radiotherapy chemotherapy were eligible for inclusion. All received (150-200mg/m2, orally, QD, d1-5/4wks) (10mg, d1-14/3wks) until or...
<p>Supplementary figure 6. Wound dehiscence.</p>
<p>A. An MR image revealed a hyperintense signal in the DWI sequence, indicating an acute ischemic stroke right ACA region (white arrows). B. CT angiography showed poor visualization of distal ACA.</p>
<p>Axial, sagittal and coronal gadolinium-enhanced FLAIR MRI at pre-baseline (A-D). Three months later, demonstrated progressive disease after anlotinib plus temozolomide (E-H).</p>
<p>A-B. Kaplan-Meier plots of progression-free survival and overall (Full analysis set). The x-axes indicated times since enrollment.</p>
<p>A-B. Kaplan-Meier plots of progression-free survival and overall (Full analysis set). The x-axes indicated times since enrollment.</p>
<p>Axial, sagittal and coronal gadolinium-enhanced MRI at pre-baseline (A-C; yellow arrows), 6 months later demonstrating complete response after anlotinib plus temozolomide (E-G). Axial Fluid-Attenuated Inversion Recovery (FLAIR, D) image pre-baseline, no progression was observed during treatment (H).</p>
<title>Abstract</title> PURPOSE To compare the therapeutic outcomes of single-session gamma knife surgery (GKS) and 2-stage GKS for large (diameter ≥ 2 cm) brain metastases from lung cancer. METHODS For first time, patients with a single primary tumor were selected, treatment data adenocarcinoma treated or between January 2019 June 2022 at our hospital retrospectively analyzed. Seventy-seven (85 lesions) in group, while 62 (72 group. Propensity score matching cases was performed because...
<p>A. An MR image revealed a hyperintense signal in the DWI sequence, indicating an acute ischemic stroke right ACA region (white arrows). B. CT angiography showed poor visualization of distal ACA.</p>